- $37.09m
- $17.20m
- $12.29m
U.S. STOCKS ON THE MOVE-Cue Health, Charles Schwab, Semtech
U.S. STOCKS ON THE MOVE-Franchise Group, Connect Biopharma, OSI Systems
Aziyo Bio hits record low as FDA declines to clear antibacterial device
FDA declines to approve Aziyo Bio's antibacterial device; shares sink
Brief: Aziyo Biologics Provides Update On FDA Submission For Cangaroo® RM Antibacterial Envelope
Aziyo Biologics Inc expected to post a loss of 63 cents a share - Earnings Preview
Aziyo Biologics Inc expected to post a loss of 63 cents a share - Earnings Preview
Aziyo Biologics Inc expected to post a loss of 63 cents a share - Earnings Preview
Brief: Aziyo Biologics Anticipates Q4 2022 Net Sales of About $12.5 Mln to $12.7 Mln
Brief: Aziyo Biologics Announces Proposed Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Caterpillar, Endava, Harpoon Therapeutics
U.S. RESEARCH ROUNDUP-Calithera Biosciences, Haynes International, Lumos Pharma
Aziyo Biologics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
Aziyo Biologics Inc expected to post a loss of 66 cents a share - Earnings Preview
Aziyo Biologics Inc expected to post a loss of 66 cents a share - Earnings Preview
Brief: Aziyo Biologics Appoints David Colpman To Board Of Directors
Brief: SWK Holdings Provides Portfolio Update
Brief: Aziyo Biologics Inc Files For Mixed Shelf Of Up To $50 Million - SEC Filing